South San Francisco, CA, June 20, 2018 – Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in...
Cognetix explored the use of snail toxins for the treatment of epilepsy, pain and anesthesia.
Salt Lake City, UT
© 2018 Pappas Capital, LLC. ALL RIGHTS RESERVED.